semaglutide and nonarteritic anterior ischemic optic neuropathy A recent Veterans Health Administration–based target trial emulation evaluated the incidence of (NAION) among adults with type 2 diabetes initiating compared with those initiating an SGLT2 Ophthalmic complications with semaglutide and

Ad Age recently sat down with Weight Watchers' Chief Marketing & Consumer Strategy Officer Nina George to discuss our recent transformation-- including a new brand, new app experience and integrated features to help members, whether on GLP-1s or not

Discover GLP-1 weight loss drugs in India (2026)

These findings align with both clinical trial data and prior real-world studies

Reddys, Cipla, and Sun Pharma are lining up to launch semaglutide versions across major global markets starting in 2026

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

There is no additional cost for split shipments.